Membrane fluidity of erythrocytes and its relevance to renin profile in essential hypertension. 1988

K Tsuda, and S Tsuda, and Y Minatogawa, and H Iwahashi, and H Shima, and H Yoshikawa, and M Ura, and J Takeda, and K Kimura, and I Nishio
Department of Internal Medicine, Wakayama Medical College, Japan.

This study was performed to investigate the membrane fluidity of hypertension by means of an electron spin resonance (E.S.R.) and a spin-labeling technique. Erythrocytes from patients with untreated essential hypertension (WHO I, II) and secondary hypertension were compared with those from normotensive subjects, and E.S.R. spectra for a fatty acid spin label agent (5-nitroxy stearate) incorporated into the erythrocyte membranes were obtained. The values of outer hyperfine splitting (2T'parallel) and order parameter (S) were significantly higher in erythrocytes from patients with essential hypertension than in those from normotensive subjects. However, these values were not significantly changed in patients with secondary hypertension compared with those in the normotensive subjects. This finding may indicate the reduced erythrocyte membrane fluidity in essential hypertension. Calcium-loading to erythrocytes with calcium-ionophore caused a greater decrease in the membrane fluidity of erythrocytes in patients with essential hypertension than in those from the normotensive subjects. This Ca-induced change in membrane fluidity was inversely correlated with plasma renin activity in essential hypertension. In addition, changes in membrane fluidity by Ca-loading in essential hypertension were inhibited by Ca-antagonists (diltiazem, verapamil). These results demonstrate that the membrane fluidity of erythrocytes might be decreased in essential hypertension, and that this abnormality could be accelerated by calcium, especially in low renin essential hypertension. Furthermore, it is suggested that Ca-antagonists might correct this Ca-abnormality at cellular levels of hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008560 Membrane Fluidity The motion of phospholipid molecules within the lipid bilayer, dependent on the classes of phospholipids present, their fatty acid composition and degree of unsaturation of the acyl chains, the cholesterol concentration, and temperature. Bilayer Fluidity,Bilayer Fluidities,Fluidities, Bilayer,Fluidities, Membrane,Fluidity, Bilayer,Fluidity, Membrane,Membrane Fluidities
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004578 Electron Spin Resonance Spectroscopy A technique applicable to the wide variety of substances which exhibit paramagnetism because of the magnetic moments of unpaired electrons. The spectra are useful for detection and identification, for determination of electron structure, for study of interactions between molecules, and for measurement of nuclear spins and moments. (From McGraw-Hill Encyclopedia of Science and Technology, 7th edition) Electron nuclear double resonance (ENDOR) spectroscopy is a variant of the technique which can give enhanced resolution. Electron spin resonance analysis can now be used in vivo, including imaging applications such as MAGNETIC RESONANCE IMAGING. ENDOR,Electron Nuclear Double Resonance,Electron Paramagnetic Resonance,Paramagnetic Resonance,Electron Spin Resonance,Paramagnetic Resonance, Electron,Resonance, Electron Paramagnetic,Resonance, Electron Spin,Resonance, Paramagnetic
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D005260 Female Females

Related Publications

K Tsuda, and S Tsuda, and Y Minatogawa, and H Iwahashi, and H Shima, and H Yoshikawa, and M Ura, and J Takeda, and K Kimura, and I Nishio
January 1993, Thrombosis and haemostasis,
K Tsuda, and S Tsuda, and Y Minatogawa, and H Iwahashi, and H Shima, and H Yoshikawa, and M Ura, and J Takeda, and K Kimura, and I Nishio
January 1995, American journal of hypertension,
K Tsuda, and S Tsuda, and Y Minatogawa, and H Iwahashi, and H Shima, and H Yoshikawa, and M Ura, and J Takeda, and K Kimura, and I Nishio
February 1989, Japanese circulation journal,
K Tsuda, and S Tsuda, and Y Minatogawa, and H Iwahashi, and H Shima, and H Yoshikawa, and M Ura, and J Takeda, and K Kimura, and I Nishio
September 1982, Clinical science (London, England : 1979),
K Tsuda, and S Tsuda, and Y Minatogawa, and H Iwahashi, and H Shima, and H Yoshikawa, and M Ura, and J Takeda, and K Kimura, and I Nishio
October 1992, Chinese medical journal,
K Tsuda, and S Tsuda, and Y Minatogawa, and H Iwahashi, and H Shima, and H Yoshikawa, and M Ura, and J Takeda, and K Kimura, and I Nishio
December 1979, Nihon rinsho. Japanese journal of clinical medicine,
K Tsuda, and S Tsuda, and Y Minatogawa, and H Iwahashi, and H Shima, and H Yoshikawa, and M Ura, and J Takeda, and K Kimura, and I Nishio
December 1976, Clinical science and molecular medicine. Supplement,
K Tsuda, and S Tsuda, and Y Minatogawa, and H Iwahashi, and H Shima, and H Yoshikawa, and M Ura, and J Takeda, and K Kimura, and I Nishio
May 2004, Polskie Archiwum Medycyny Wewnetrznej,
K Tsuda, and S Tsuda, and Y Minatogawa, and H Iwahashi, and H Shima, and H Yoshikawa, and M Ura, and J Takeda, and K Kimura, and I Nishio
November 1991, Fukuoka igaku zasshi = Hukuoka acta medica,
K Tsuda, and S Tsuda, and Y Minatogawa, and H Iwahashi, and H Shima, and H Yoshikawa, and M Ura, and J Takeda, and K Kimura, and I Nishio
April 1978, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
Copied contents to your clipboard!